Skip to content
10-Q

Quarterly Report

PALISADE BIO, INC. PALI

0000950170-25-069204

← back to feed
Filed
May 12, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2025 · May 8, 2025 4.8M sh
Current Liabilities Q1 2025 · Mar 31, 2025 $2.78M
Current Liabilities Q1 2025 · Dec 31, 2024 $3.24M
Total Liabilities Q1 2025 · Mar 31, 2025 $2.86M
Total Liabilities Q1 2025 · Dec 31, 2024 $3.39M
Current Assets Q1 2025 · Mar 31, 2025 $7.89M
Current Assets Q1 2025 · Dec 31, 2024 $10.49M
Total Assets Q1 2025 · Mar 31, 2025 $8.19M
Total Assets Q1 2025 · Dec 31, 2024 $10.88M
Cash And Equivalents Q1 2025 · Dec 31, 2024 $9.82M
Cash And Equivalents Q1 2025 · Mar 31, 2024 $11.28M
Shares Diluted Q1 2025 · Mar 31, 2024 768.14K sh
Operating Cash Flow Q1 2025 · Mar 31, 2024 −$3.18M
Stockholders Equity Q1 2025 · Mar 31, 2024 $10.06M
Stockholders Equity Q1 2025 · Dec 31, 2023 $11.31M
Eps Diluted Q1 2025 · Mar 31, 2024 −$4.59
Eps Basic Q1 2025 · Mar 31, 2024 −$4.59
Net Income Q1 2025 · Mar 31, 2024 −$3.53M
Operating Income Q1 2025 · Mar 31, 2024 −$3.67M